Reviewed for accuracy and claims compliance: Claims and compliance review
Weight-management demand in India has a sharp annual peak, and it is the most predictable thing in this industry.
It starts building in the last week of December, peaks through the first three weeks of January, and is substantially over by mid-February.
Everyone knows this. And every year, brands place the order that was supposed to serve it in the second week of December, which means stock arrives in late January, into a market that is already past its peak, and then sits for eleven months.
So this article is the arithmetic backwards from January, plus an honest account of why this is one of the hardest categories to serve well.
This is orientation, not legal, regulatory, financial or medical advice. Claims rules and market conditions change. Verify the regulatory position with a competent consultant, and see a doctor for any health decision.
Working backwards from the first week of January
Count the steps in reverse, and the answer stops being surprising.
Stock must be with the seller, listed and live, by late December, because the searches start before the month ends and a listing with no reviews and no sales history will not capture them.
Which means dispatch from the plant by early to mid-December, allowing for transit and, for marketplace fulfilment, inbound processing time at the warehouse, which is not instant in December.
Which means manufacturing complete by late November or early December.
Which means the manufacturing slot booked, with raw material secured, by late October or early November, and November is a crowded month in Indian manufacturing because of festive and winter production.
Which means artwork finalised and plates made by October, since plates need approved artwork, and artwork needs a claims review you should not rush.
Which means the formulation and the specification locked by September.
And if the product is new rather than a repeat, add formulation development, trial batches and stability work ahead of all of that, which pushes the real decision point to August.
So: a January peak is served by a September decision, or an August one for a new product. December is not late. December is the wrong year.
What happens when you are late
Three outcomes, and brands usually expect only the first.
You miss the peak and sell into February and March at a discount, because demand has gone and you are competing with everyone else who was also late.
You hold inventory for eleven months, paying for the warehouse and losing shelf life. A 24-month product manufactured in January and sold the following January is halfway through its life before it moves.
And you damage the listing. A product launched into a declining market gets poor early sales velocity and few reviews, and that weak start is what the next January inherits.
That third one is the expensive one, and nobody prices it.
The honest problem with this category
And we have to say this even though we manufacture for it.
Weight management has the worst repeat purchase in the supplement business, and the reason is structural rather than accidental.
The customer buys in January expecting a result, in a category where the honest claim is modest and the marketing claim usually is not. By March they have concluded it did not work.
And they are often right, because what was promised was a specific quantity of loss in a specific time, which no supplement delivers on its own.
Which means the January peak is substantially a new-customer market every year. You pay acquisition cost on every sale, every year, with almost no compounding.
That changes the economics completely: a category with no repeat purchase needs a much higher margin per sale to work, and the marketplace commission and advertising costs in January, the most competitive advertising month in this category, are at their worst exactly when you need them lowest.
What we will and will not make for this season
Stating it plainly, because this is the season when we are asked most often.
We will not print a numeric loss promise. “Lose 12 kg in 2 months” or any variant, in any language or transliteration.
We will not print “fat burner”, “fat cutter” or metabolic claims presented as outcomes.
We will not print before-and-after imagery.
We will not print “natural” appetite suppression claims, which carry a safety dimension as well as a regulatory one.
And we decline formulations with undeclared stimulants, which is a real category of problem product in this season specifically.
What we will make: honestly specified products with real ingredients at real standardisation, labelled with their cautions, sold on their composition.
And we tell clients, at the time of quoting, that this category’s repeat rate is poor and that a January-only product is a harder business than it looks. We lose orders saying it.
The better way to serve this demand
Four approaches that work better than the obvious one.
Sell a product that has a January use and an all-year use. A protein or a general nutrition product with a genuine role beyond the resolution season sells in January without depending on January. The January demand becomes a lift rather than the whole business.
Sell the practical content, not the promise. In a category where the compliant claim is modest, the brands that keep customers are the ones that were honest in January about what the product does and does not do. That reads as a weaker offer and produces a better February.
Plan the exit as well as the entry. Decide in advance how much stock you want remaining on 1 February and order to that number, not to the peak. Running out in the third week of January is a better outcome than holding six months of stock in March.
And consider not entering at all if this is your first product. The January peak is the most competitive advertising window in the category, against brands with review histories, in a segment with no repeat purchase. It is the hardest possible place to start, and it looks like the easiest because the demand is visible.
The calendar, in one place
August, decide, if the product is new. Formulation development, trial batches, stability.
September, lock the formulation and specification. Confirm quantities.
October, artwork finalised, claims review completed, plates made. Book the manufacturing slot and secure raw material.
November, manufacture. Testing and release.
Early December, dispatch. Inbound to warehouses. Listings created and live.
Late December, stock live, content published, advertising prepared.
January, sell.
February, review what remains against the number you planned for.
And if you are reading this in December with no stock booked, the useful decision is to plan for next January rather than to rush this one. A rushed product that arrives in late January is the worst of every available option.
The short version
- The peak builds from late December, peaks for three weeks, ends by mid-February
- Everyone knows it and brands still order in December
- Stock must be live by late December to capture early searches
- So dispatch by early-to-mid December, allowing inbound processing
- So manufacturing complete by late November
- So the slot booked and material secured by late October
- November is already crowded with festive and winter production
- So artwork and plates by October, after an unrushed claims review
- So formulation and specification locked by September
- A new product adds development, trials and stability, decide in August
- December is not late; December is the wrong year
- Being late means discounting into February and March
- And holding inventory for eleven months, losing shelf life
- A product made in January and sold next January is half-expired
- And a weak launch velocity is what next January inherits
- Nobody prices that third cost
- This category has the worst repeat purchase in the business
- The customer expected a result the honest claim never promised
- So the peak is a new-customer market every single year
- Acquisition cost recurs with almost no compounding
- And January is the most expensive advertising month in the category
- We will not print numeric loss promises in any language
- No “fat burner”, no metabolic outcome claims, no before-and-after
- No appetite suppression claims, which carry a safety dimension
- And we decline formulations with undeclared stimulants
- Which is a real problem category in this season specifically
- We tell clients the repeat rate is poor, and lose orders for it
- Better: sell a product with a January use and an all-year use
- The peak becomes a lift rather than the whole business
- Sell the practical content, not the promise, worse January, better February
- Plan the exit: order to your 1 February remainder, not to the peak
- Selling out in week three beats holding six months of stock in March
- And consider not entering at all with a first product
- It is the hardest place to start and looks like the easiest
- Reading this in December with nothing booked? Plan for next year
Related guides: the seasonal demand calendar, supplement costing and margins, how to start a supplement brand in India. Related reading: when to order stock for each season, winter respiratory season, the October deadline, choosing a category you can actually win, and the claims that get your listing pulled.
Get our product list and minimum orders
Leave your email and we will send the formats we make, the minimum order for each and typical lead times. We use it only to reply to you.
Manufacturing in this category?
We make products in this category for other people's brands. Tell us the format and volume and we will send a specification and a per-unit cost.
Request a quotation ↗NutraHerbal manufactures food supplements, Ayurvedic proprietary medicines and cosmetics for business customers. Product information on this site describes composition, format and commercial positioning for brand owners. It is not medical advice, does not claim to diagnose, treat, cure or prevent any disease, and is not a substitute for consulting a qualified practitioner. Final label claims are the brand owner's responsibility and must be approved for the destination market.
How we write and review content: editorial policy.

